Eton Pharmaceuticals Inc. logo

Eton Pharmaceuticals Inc. (ETON)

Market Closed
3 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
27. 61
+0.21
+0.77%
$
887.51M Market Cap
- P/E Ratio
- Div Yield
325,224 Volume
0.26 Eps
$ 27.4
Previous Close
Add Transaction
Day Range
26.66 27.62
Year Range
13.09 35.66
Want to track ETON and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Here's Why Momentum in Eton Pharmaceuticals (ETON) Should Keep going

Here's Why Momentum in Eton Pharmaceuticals (ETON) Should Keep going

Eton Pharmaceuticals (ETON) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks | 1 year ago
Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?

Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?

Eton Pharmaceuticals (ETON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks | 1 year ago
What Makes Eton Pharmaceuticals (ETON) a Good Fit for 'Trend Investing'

What Makes Eton Pharmaceuticals (ETON) a Good Fit for 'Trend Investing'

Eton Pharmaceuticals (ETON) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Zacks | 1 year ago
Eton Pharmaceuticals, Inc. (ETON) Q3 2024 Earnings Call Transcript

Eton Pharmaceuticals, Inc. (ETON) Q3 2024 Earnings Call Transcript

Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants David Krempa – Chief Business Officer Sean Brynjelsen – Chief Executive Officer James Gruber – Chief Financial Officer Conference Call Participants Chase Knickerbocker – Craig-Hallum Operator Good afternoon, and welcome to the Eton Pharmaceuticals Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in listen-only mode.

Seekingalpha | 1 year ago
Eton Pharmaceuticals, Inc. (ETON) Q2 2024 Earnings Call Transcript

Eton Pharmaceuticals, Inc. (ETON) Q2 2024 Earnings Call Transcript

Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants David Krempa - Chief Business Officer Sean Brynjelsen - Chief Executive Officer James Gruber - Chief Financial Officer Conference Call Participants Chase Knickerbocker - Craig-Hallum Operator Good afternoon, and welcome to the Eaton Pharmaceuticals Second Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please be advised, this call is being recorded at the company's request.

Seekingalpha | 1 year ago